- Home
- PBM vs CNSP Comparison
PBM vs CNSP Comparison
Compare PBM & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBM
- CNSP
- Stock Information
- Founded
- PBM 1994
- CNSP 2017
- Country
- PBM Canada
- CNSP United States
- Employees
- PBM N/A
- CNSP N/A
- Industry
- PBM
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- PBM
- CNSP Health Care
- Exchange
- PBM NYSE
- CNSP Nasdaq
- Market Cap
- PBM 7.5M
- CNSP 6.5M
- IPO Year
- PBM N/A
- CNSP 2019
- Fundamental
- Price
- PBM $1.79
- CNSP $0.10
- Analyst Decision
- PBM
- CNSP Strong Buy
- Analyst Count
- PBM 0
- CNSP 1
- Target Price
- PBM N/A
- CNSP $0.50
- AVG Volume (30 Days)
- PBM 5.4M
- CNSP 30.2M
- Earning Date
- PBM 02-02-2025
- CNSP 11-15-2024
- Dividend Yield
- PBM N/A
- CNSP N/A
- EPS Growth
- PBM N/A
- CNSP N/A
- EPS
- PBM N/A
- CNSP N/A
- Revenue
- PBM N/A
- CNSP N/A
- Revenue This Year
- PBM N/A
- CNSP N/A
- Revenue Next Year
- PBM N/A
- CNSP N/A
- P/E Ratio
- PBM N/A
- CNSP N/A
- Revenue Growth
- PBM N/A
- CNSP N/A
- 52 Week Low
- PBM $1.51
- CNSP $0.10
- 52 Week High
- PBM $593.25
- CNSP $40.70
- Technical
- Relative Strength Index (RSI)
- PBM 39.22
- CNSP 39.58
- Support Level
- PBM $1.61
- CNSP $0.10
- Resistance Level
- PBM $2.25
- CNSP $0.11
- Average True Range (ATR)
- PBM 0.22
- CNSP 0.02
- MACD
- PBM 0.06
- CNSP -0.00
- Stochastic Oscillator
- PBM 23.38
- CNSP 3.02
About PBM PSYENCE BIOMEDICAL LTD
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.